🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is conducted to determine the safety, tolerability, pharmacokine...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2022-01-05
Trial ID
NCT05430386
Treatments Being Tested
HS-10241, an oral and highly selective MET-TKI, may contribute to overcomin...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-30
Trial ID
NCT06110663
Treatments Being Tested
To investigate safety, tolerability and pharmacokinetics of C-met Kinase In...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2016-11
Trial ID
NCT02977364
Treatments Being Tested
This study will be conducted in subjects with moderate Hepatic Impairment, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-28
Trial ID
NCT06823245
Treatments Being Tested
HS-10241 is a highly potent and selective small molecule inhibitor of c-Met...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2019-06-21
Trial ID
NCT04477057
Treatments Being Tested
This is a phase 1, open-label, dose-escalation trial of HS-10241 as monothe...
Status
Completed
Location
Chris O'Brien Lifehouse
Start Date
2016-09
Trial ID
NCT02759640
Treatments Being Tested
To investigate tolerability, safety, pharmacokinetics and efficacy of C-met...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2017-08-08
Trial ID
NCT03243643